EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
EASL-EASD-EASO 代謝異常相關脂肪肝疾病(MASLD)管理的臨床實踐指南。
J Hepatol 2024-06-09
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
EASL-EASD-EASO 代謝功能異常相關脂肪肝疾病(MASLD)管理臨床指南。
Obes Facts 2024-06-09
Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?
代謝異常相關脂肪肝疾病的藥物治療選擇:我們今天的現況如何?
Expert Opin Pharmacother 2024-07-02
NAFLD vs MASLD (metabolic dysfunction associated steatotic liver disease) - why the need for a change of nomenclature?
NAFLD 與 MASLD(代謝功能障礙相關脂肪肝病) - 為何需要改變命名?
J Clin Endocrinol Metab 2025-02-19
Current priorities in research on metabolic-associated fatty liver disease based on the results of EASL - 2024.
基於 EASL - 2024 的結果,代謝相關脂肪肝疾病研究的當前優先事項。
Pol Merkur Lekarski 2025-03-10